SLC5A5 and cancer: Oncolytic virotherapy has recently gained attention due to demonstration of the first cancer patient who experienced a complete remission that has been ongoing for more than five years now following treatment with a single high-dose shot of recombinant oncolytic measles vaccine virus expressing the sodium iodide symporter (MeV-NIS) [11].